Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AtriCure (ATRC) Revenue (2016 - 2025)

AtriCure (ATRC) has disclosed Revenue for 16 consecutive years, with $140.5 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 13.05% to $140.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $534.5 million through Dec 2025, up 14.88% year-over-year, with the annual reading at $534.5 million for FY2025, 14.88% up from the prior year.
  • Revenue for Q4 2025 was $140.5 million at AtriCure, up from $134.3 million in the prior quarter.
  • The five-year high for Revenue was $140.5 million in Q4 2025, with the low at $59.3 million in Q1 2021.
  • Average Revenue over 5 years is $100.2 million, with a median of $99.6 million recorded in 2023.
  • Peak annual rise in Revenue hit 74.84% in 2021, while the deepest fall reached 11.37% in 2021.
  • Over 5 years, Revenue stood at $73.2 million in 2021, then increased by 20.23% to $88.0 million in 2022, then rose by 21.03% to $106.5 million in 2023, then grew by 16.64% to $124.3 million in 2024, then increased by 13.05% to $140.5 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $140.5 million, $134.3 million, and $136.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.